| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.0004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |